作者:
Prabhu P,Gounder [1]
;
Anders,Koch [2]
;
Ginger,Provo [3]
;
Astrid,Lovlie [4]
;
Josefine Lundberg,Ederth [5]
;
Maria,Axelsson [6]
;
Chris P,Archibald [7]
;
Brendan,Hanley [8]
;
Angie,Mullen [9]
;
Myrna,Matheson [10]
;
David,Allison [11]
;
Henrik,Trykker [12]
;
Thomas W,Hennessy [13]
;
Markku,Kuusi [1]
;
Vladimir,Chulanov [14]
;
Brian J,McMahon [15]
作者单位:
Arctic Investigations Program, Division of Preparedness and Emerging Infections, National Center for Emerging and Zoonotic Infectious Diseases, U.S. Centers for Disease Control and Prevention (CDC), Anchorage, Alaska, USA.
[1]
Statens Serum Institut, Copenhagen, Denmark.
[2]
Lisimatusarfik, University of Greenland, Nuuk, Greenland.
[3]
Division of Public Health, State of Alaska, Anchorage, Alaska, USA.
[4]
Department for Infectious Disease Registries, Norwegian Institute of Public Health, Oslo, Norway.
[5]
Department of Public Health Analysis and Data Management, Public Health Agency of Sweden, Stockholm, Sweden.
[6]
Unit for Epidemiology & Health Economic, the Public Health Agency of Sweden, Stockholm, Sweden.
[7]
Surveillance and Epidemiology Division, Centre for Communicable Diseases and Infection Control, Public Health Agency of Canada, Ottawa, Canada.
[8]
Chief Medical Officer of Health, Whitehorse, Yukon, Canada.
[9]
Department of Health, Government of Nunavut, Iqaluit, Nunavut, Canada.
[10]
Communicable Disease Control Unit, Department of Health and Social Services, Government of the Northwest Territories, Yellowknife, Northwest Territories, Canada.
[11]
Department of Health and Community Services, St. John's, Newfoundland and Labrador, Canada.
[12]
National Board of Health, Nuuk, Greenland.
[13]
National Institute for Health and Welfare (THL), Helsinki, Finland.
[14]
Central Research Institute of Epidemiology, Reference Center for Viral Hepatitis, Moscow, Russia.
[15]
Liver Diseases and Hepatitis Program, Alaska Native Tribal Health Consortium, Anchorage, Alaska, USA.
[16]
DOI
10.2807/1560-7917.ES.2018.23.40.1700408
PMID
30301489
发布时间
2022-09-15